TCDA Chart
- 52-Week Range: $0.01 - $13.60
- Market Capitalization: $6.27M
- Short Percentage: 0%
- Target Price: $20.00
- Shares Outstanding: 58.03M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
TCDA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Tricida, Inc.Newsfile Corp | February 8th
- Tricida files for Chapter 11 bankruptcy protection as it searches for a buyerProactive Investors | January 12th
- Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of VeverimerBusiness Wire | October 24th
- Tricida Announces $125 Million Debt Facility with Hercules CapitalBusiness Wire | October 19th
- Tricida to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceBusiness Wire | September 6th
- Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | August 8th
Company Info
Website: https://www.tricida.com
Address: 7000 Shoreline Court, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 57
Address: 7000 Shoreline Court, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 57
$TCDA has just been halted from trading due to volatility.
$TCDA has just been halted from trading.
$TCDA this is going to skyrocket tmr!!!
$TCDA God dammit
$TCDA how low can she go
$TCDA very nice
$TCDA bears haha
$TCDA low volume
expect flat or negative close
$TCDA every dip gets bought up.
$TCDA Nothing but time to wait